End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51.92 CNY | -1.10% |
|
-1.70% | -11.94% |
Jun. 16 | Suzhou Kematek, Inc.(SZSE:301611) added to Shenzhen Stock Exchange Component A Share Index | CI |
Jun. 15 | Suzhou Kematek, Inc.(SZSE:301611) added to Shenzhen Stock Exchange Component Index | CI |
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Profitability | ||||||
Return on Assets | 12.2 | 9.13 | 6.93 | 4.31 | 12.71 | |
Return on Total Capital | 17.38 | 11.65 | 8.75 | 5.66 | 16.46 | |
Return On Equity % | 34.56 | 19.48 | 15.73 | 11.86 | 27.57 | |
Return on Common Equity | 34.56 | 19.48 | 15.73 | 11.86 | 27.57 | |
Margin Analysis | ||||||
Gross Profit Margin % | 38.63 | 41.81 | 41.14 | 38.62 | 56.93 | |
SG&A Margin | 12.27 | 13.14 | 11.41 | 12.19 | 9.47 | |
EBITDA Margin % | 26.2 | 27.28 | 27.22 | 23.56 | 45.12 | |
EBITA Margin % | 19.89 | 22.34 | 21.57 | 17.03 | 39.38 | |
EBIT Margin % | 19.87 | 22.32 | 21.55 | 17.02 | 39.34 | |
Income From Continuing Operations Margin % | 17.98 | 19.45 | 20.16 | 17.04 | 36.27 | |
Net Income Margin % | 17.98 | 19.45 | 20.16 | 17.04 | 36.27 | |
Net Avail. For Common Margin % | 17.98 | 19.45 | 20.16 | 17.04 | 36.27 | |
Normalized Net Income Margin | 11.59 | 13.32 | 13.35 | 10.6 | 24.43 | |
Levered Free Cash Flow Margin | 8.47 | -21.11 | -24 | -36.23 | -6.31 | |
Unlevered Free Cash Flow Margin | 9.07 | -20.33 | -23.63 | -35.69 | -5.93 | |
Asset Turnover | ||||||
Asset Turnover | 0.98 | 0.65 | 0.51 | 0.41 | 0.52 | |
Fixed Assets Turnover | 2.77 | 2.38 | 1.62 | 0.98 | 1.22 | |
Receivables Turnover (Average Receivables) | 3.03 | 2.64 | 2.34 | 1.82 | 2.11 | |
Inventory Turnover (Average Inventory) | 4.8 | 3.11 | 2.43 | 1.93 | 1.9 | |
Short Term Liquidity | ||||||
Current Ratio | 1.27 | 2.88 | 2.79 | 1.74 | 3.04 | |
Quick Ratio | 0.86 | 2.37 | 2.03 | 1.17 | 2.39 | |
Operating Cash Flow to Current Liabilities | 0.36 | 0.01 | 0.28 | 0.13 | 0.66 | |
Days Sales Outstanding (Average Receivables) | 120.8 | 138.25 | 156.15 | 200.62 | 173.57 | |
Days Outstanding Inventory (Average Inventory) | 76.22 | 117.28 | 150.04 | 188.99 | 193.02 | |
Average Days Payable Outstanding | 66.26 | 69.94 | 63.06 | 107.62 | 132.87 | |
Cash Conversion Cycle (Average Days) | 130.76 | 185.59 | 243.14 | 282 | 233.72 | |
Long Term Solvency | ||||||
Total Debt/Equity | 28.73 | 17.52 | 22.34 | 38.34 | 1.51 | |
Total Debt / Total Capital | 22.32 | 14.91 | 18.26 | 27.71 | 1.49 | |
LT Debt/Equity | 0.12 | 4.51 | 17.1 | 24.37 | 1.07 | |
Long-Term Debt / Total Capital | 0.09 | 3.84 | 13.98 | 17.61 | 1.05 | |
Total Liabilities / Total Assets | 47 | 30.23 | 36.99 | 45.44 | 22.77 | |
EBIT / Interest Expense | 20.98 | 17.89 | 35.64 | 19.44 | 65.13 | |
EBITDA / Interest Expense | 27.67 | 23.41 | 48.48 | 29.1 | 76.49 | |
(EBITDA - Capex) / Interest Expense | 18.55 | 6.17 | -9.77 | -30.95 | 29.29 | |
Total Debt / EBITDA | 0.64 | 0.94 | 1.06 | 2.31 | 0.06 | |
Net Debt / EBITDA | 0.48 | -1.69 | -0.34 | 1.22 | -0.76 | |
Total Debt / (EBITDA - Capex) | 0.95 | 3.57 | -5.26 | -2.17 | 0.15 | |
Net Debt / (EBITDA - Capex) | 0.72 | -6.4 | 1.68 | -1.15 | -1.97 | |
Growth Over Prior Year | ||||||
Total Revenues, 1 Yr. Growth % | 44.74 | 35.75 | 34.04 | 3.89 | 78.45 | |
Gross Profit, 1 Yr. Growth % | 27.46 | 46.94 | 31.9 | -2.49 | 162.07 | |
EBITDA, 1 Yr. Growth % | 119.19 | 41.31 | 28.52 | -10.09 | 220.48 | |
EBITA, 1 Yr. Growth % | 188.64 | 52.48 | 23.27 | -17.97 | 277.94 | |
EBIT, 1 Yr. Growth % | 188.97 | 52.49 | 23.26 | -17.93 | 281.87 | |
Earnings From Cont. Operations, 1 Yr. Growth % | 263.29 | 46.84 | 38.97 | -12.2 | 279.88 | |
Net Income, 1 Yr. Growth % | 263.29 | 46.84 | 38.97 | -12.2 | 279.88 | |
Normalized Net Income, 1 Yr. Growth % | 210.3 | 55.94 | 27.69 | -17.53 | 281.18 | |
Diluted EPS Before Extra, 1 Yr. Growth % | 273.4 | 40.6 | 22.99 | -12.2 | 252.17 | |
Accounts Receivable, 1 Yr. Growth % | 21.65 | 85.32 | 33.37 | 32.85 | 70.09 | |
Inventory, 1 Yr. Growth % | 84.1 | 106.43 | 57.49 | 23.13 | 31.1 | |
Net Property, Plant and Equip., 1 Yr. Growth % | 1.45 | 114.66 | 88.84 | 63.27 | 29.38 | |
Total Assets, 1 Yr. Growth % | 15.92 | 179.38 | 31.62 | 32.13 | 45.75 | |
Tangible Book Value, 1 Yr. Growth % | 23.83 | 277.6 | 17.36 | 14.53 | 108.94 | |
Common Equity, 1 Yr. Growth % | 25.69 | 267.77 | 18.87 | 14.42 | 106.31 | |
Cash From Operations, 1 Yr. Growth % | 24.24 | -95.39 | 2.75K | -17.4 | 393.49 | |
Capital Expenditures, 1 Yr. Growth % | -20.72 | 238 | 119.57 | 55.12 | -3.26 | |
Levered Free Cash Flow, 1 Yr. Growth % | - | -438.21 | 56.78 | 56.82 | -69.03 | |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | -404.45 | 60.4 | 56.92 | -70.44 | |
Compound Annual Growth Rate Over Two Years | ||||||
Total Revenues, 2 Yr. CAGR % | - | 40.17 | 34.89 | 18.01 | 36.16 | |
Gross Profit, 2 Yr. CAGR % | - | 36.86 | 39.22 | 13.41 | 60.17 | |
EBITDA, 2 Yr. CAGR % | - | 76 | 37.49 | 7.5 | 75.3 | |
EBITA, 2 Yr. CAGR % | - | 109.79 | 40.48 | 0.55 | 83.98 | |
EBIT, 2 Yr. CAGR % | - | 109.92 | 40.48 | 0.58 | 83.97 | |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | 130.97 | 42.85 | 10.46 | 82.63 | |
Net Income, 2 Yr. CAGR % | - | 130.97 | 42.85 | 10.46 | 82.63 | |
Normalized Net Income, 2 Yr. CAGR % | - | 119.98 | 44.76 | 2.62 | 84.2 | |
Diluted EPS Before Extra, 2 Yr. CAGR % | - | 129.13 | 31.5 | 3.91 | 77.09 | |
Accounts Receivable, 2 Yr. CAGR % | - | 50.15 | 57.21 | 33.11 | 50.32 | |
Inventory, 2 Yr. CAGR % | - | 94.95 | 80.3 | 39.25 | 27.05 | |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | 47.57 | 101.34 | 75.59 | 45.34 | |
Total Assets, 2 Yr. CAGR % | - | 79.96 | 91.76 | 31.88 | 38.77 | |
Tangible Book Value, 2 Yr. CAGR % | - | 116.24 | 110.51 | 15.94 | 54.69 | |
Common Equity, 2 Yr. CAGR % | - | 115 | 109.08 | 16.62 | 53.64 | |
Cash From Operations, 2 Yr. CAGR % | - | -76.08 | 14.56 | 385.11 | 101.9 | |
Capital Expenditures, 2 Yr. CAGR % | - | 63.69 | 172.43 | 84.55 | 22.5 | |
Levered Free Cash Flow, 2 Yr. CAGR % | - | - | 127.04 | 56.8 | -30.21 | |
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | - | 117.77 | 58.65 | -31.79 | |
Compound Annual Growth Rate Over Three Years | ||||||
Total Revenues, 3 Yr. CAGR % | - | - | 38.1 | 23.65 | 35.45 | |
Gross Profit, 3 Yr. CAGR % | - | - | 35.18 | 23.64 | 50.13 | |
EBITDA, 3 Yr. CAGR % | - | - | 60.62 | 19.34 | 58.07 | |
EBITA, 3 Yr. CAGR % | - | - | 78.59 | 17.42 | 60.99 | |
EBIT, 3 Yr. CAGR % | - | - | 78.66 | 17.44 | 60.98 | |
Earnings From Cont. Operations, 3 Yr. CAGR % | - | - | 94.99 | 21.46 | 66.73 | |
Net Income, 3 Yr. CAGR % | - | - | 94.99 | 21.46 | 66.73 | |
Normalized Net Income, 3 Yr. CAGR % | - | - | 86.65 | 20 | 63.02 | |
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | 86.21 | 14.93 | 56.83 | |
Accounts Receivable, 3 Yr. CAGR % | - | - | 44.33 | 48.63 | 44.45 | |
Inventory, 3 Yr. CAGR % | - | - | 81.56 | 58.78 | 36.48 | |
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | 60.22 | 87.75 | 58.6 | |
Total Assets, 3 Yr. CAGR % | - | - | 62.14 | 69.38 | 36.35 | |
Tangible Book Value, 3 Yr. CAGR % | - | - | 76.39 | 71.85 | 41.08 | |
Common Equity, 3 Yr. CAGR % | - | - | 76.46 | 71.02 | 41.04 | |
Cash From Operations, 3 Yr. CAGR % | - | - | 17.7 | 2.73 | 387.89 | |
Capital Expenditures, 3 Yr. CAGR % | - | - | 80.53 | 125.8 | 48.81 | |
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | - | 100.7 | -8.6 | |
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | - | 95.24 | -9.3 | |
Compound Annual Growth Rate Over Five Years | ||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | - | 37.32 | |
Gross Profit, 5 Yr. CAGR % | - | - | - | - | 44.67 | |
EBITDA, 5 Yr. CAGR % | - | - | - | - | 66.34 | |
EBITA, 5 Yr. CAGR % | - | - | - | - | 80.73 | |
EBIT, 5 Yr. CAGR % | - | - | - | - | 80.77 | |
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | - | - | 89.95 | |
Net Income, 5 Yr. CAGR % | - | - | - | - | 89.95 | |
Normalized Net Income, 5 Yr. CAGR % | - | - | - | - | 85.66 | |
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | - | 82.51 | |
Accounts Receivable, 5 Yr. CAGR % | - | - | - | - | 46.7 | |
Inventory, 5 Yr. CAGR % | - | - | - | - | 57.4 | |
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | - | 54.09 | |
Total Assets, 5 Yr. CAGR % | - | - | - | - | 52.36 | |
Tangible Book Value, 5 Yr. CAGR % | - | - | - | - | 67.36 | |
Common Equity, 5 Yr. CAGR % | - | - | - | - | 66.95 | |
Cash From Operations, 5 Yr. CAGR % | - | - | - | - | 46.05 | |
Capital Expenditures, 5 Yr. CAGR % | - | - | - | - | 54.59 |
- Stock Market
- Equities
- 301611 Stock
- Financials Suzhou Kematek, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions